Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
6/20/24 Johnson & Johnson (JNJ) Tremfya for Crohn's Disease Subscribers Only Subscribers Only Subscribers Only
6/20/24 Gilead Sciences (GILD) Sunlenca for HIV Prevention Subscribers Only Subscribers Only Subscribers Only
6/19/24 Woolsey Bravyl for Amyotrophic Lateral Sclerosis (ALS) Subscribers Only Subscribers Only Subscribers Only
6/18/24 AstraZeneca (AZN) Truqap for Triple-Negative Breast Cancer (TNBC) Subscribers Only Subscribers Only Subscribers Only
6/18/24 Intra-Cellular Therapies (ITCI) Caplyta for Major Depressive Disorder (MDD) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
02/29/24 Subscribers Only Subscribers Only Trial Data - Top-Line Results
03/19/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/09/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/18/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/01/25 - 04/30/24 Subscribers Only Subscribers Only Trial Announcement - Initiation